Karen Fisher insider trades: Repro Med Systems (KRMD) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Karen reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 7, 2020 | KRMD | ↑ Buy | 500 | $5.60 | $3K | Direct | Dec 7, 2020 (0d) |
| Dec 3, 2020 | KRMD | ↑ Buy | 250 | $5.30 | $1K | Direct | Dec 3, 2020 (0d) |
| Aug 20, 2007 | GTAX.PK | ↑ Buy | 30,000 | $0.10 | $3K | Direct | Aug 22, 2007 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KRMD insiders
Open-market trades in the last 12 months
About Karen Fisher's insider trades
Karen Fisher is Chief Financial Officer at Repro Med Systems (KRMD). Since Aug 20, 2007, Karen has reported 3 open-market purchases worth $7K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (2 filings), grants and awards (2 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KRMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.